Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2557-2563

  Co, Edgie Mark A ^a   Dennull, Richard A ^a   Reinbold, Drew D ^a   Waters, Norman C ^a,b   Johnson, Jacob D ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ATOVAQUONE PLUS CHLOROQUINE; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN PLUS CHLOROQUINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG SCREENING; DRUG SENSITIVITY; FLUORESCENCE ANALYSIS; IC 50; IN VITRO STUDY; MALARIA; MALARIA SYBR GREEN I BASED FLUORESCENCE ASSAY; MIXED INFECTION; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; POPULATION DYNAMICS; PRIORITY JOURNAL; RELIABILITY; SIMULATION;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; FLUORESCENT DYES; HYPOXANTHINE; MEFLOQUINE; ORGANIC CHEMICALS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM;

EID: 67049168786     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01370-08     Document Type: Article

References (42)

1. Bacon, D. J., C. Latour, C. Luca, O. Colina, P. Ringwald, and S. Picot. 2007. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob. Agents Chemother. 51:1172-1178.
2. Baniecki, M. L., D. F. Wirth, and J. Clardy. 2007. High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob. Agents Chemother. 51:716-723.
3. Basco, L. K., and J. Le Bras. 1994. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine, and artemisinin derivatives. Ann. Trop. Med. Parasitol. 88:137-144.
4. Basco, L. K., and J. Le Bras. 1990. Reversal of chloroquine resistance with desipramine in isolates of Plasmodium falciparum from Central and West Africa. Trans. R. Soc. Trop. Med. Hyg. 84:479-481.
5. Bell, A. 2005. Antimalarial drug synergism and antagonism: mechanistic and clinical significance. FEMS Microbiol. Lett. 253:171-184.
6. Berenbaum, M. C. 1978. A method for testing for synergy with any number of agents. J. Infect. Dis. 137:122-130.
7. Canfield, C. J., M. Pudney, and E. Gutteridge. 1995. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp. Parasitol. 80:373-381.
8. Chretien, J. P., M. Fukuda, and H. Noedl. 2007. Improving surveillance for antimalarial drug resistance. JAMA 297:2278-2281. (Pubitemid 47010884)
9. Clinical and Laboratory Standards Institute. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard, 7th ed., CLSI document M11-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Corbett, Y., L. Herrera, J. Gonzalez, L. Cubilla, T. L. Capson, P. D. Coley, T. A. Kursar, L. I. Romero, and E. Ortega-Barria. 2004. A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. Am. J. Trop. Med. Hyg. 70:119-124.
11. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
12. Fidock, D. A., and E. H. Ekland. 2008. In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes. Int. J. Parasitol. 38:743-747.
13. Happi, C. T., G. O. Gbotosho, A. Swowunmi, C. O. Falade, D. O. Akinboye, L. Gerena, D. E. Kyle, W. Milhous, D. F. Wirth, and A. M. J. Oduola. 2004. Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. Am. J. Trop. Med. Hyg. 70:20-26.
14. Happi, C. T., G. O. Gbotosho, O. A. Folarin, D. O. Akinboye, B. O. Yusuf, O. O. Ebong, A. Swowunmi, D. E. Kyle, W. Milhous, D. F. Wirth, and A. M. J. Oduola. 2005. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Trop. 95:183-193.
15. Hastings, I. M., and U. D' Alessandro. 2000. Modelling a predictable disaster: the rise and spread of drug-resistant malaria. Parasitol. Today 16:340-347. (Pubitemid 30460031)
16. Hyde, J. E. 2002. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes Infect. 4:165-174.
17. Johnson, J. D., R. A. Dennull, L. Gerena, M. Lopez-Sanchez, N. E. Roncal, and N. C. Waters. 2007. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob. Agents Chemother. 51:1926-1933.
18. Jorgensen, J. H., and M. J. Ferraro. 2000. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms. Clin. Infect. Dis. 30:799-808.
19. Kosaisavee, V., R. Suwanarusk, F. Nosten, D. E. Kyle, M. Barrends, J. Jones, R. Price, B. Russell, and U. Lek-Uthai. 2006. Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates. Exp. Parasitol. 114:34-39.
20. Liu, S., J. Mu, H. Jiang, and X.-Z. Su. 2008. Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping. Am. J. Trop. Med. Hyg. 79:178-184.
21. Lorenzetti, A., P. A. Fornazari, A. C. Bonini-Domingos, R. D. S. R. Penhalbel, É. Fugikaha, C. R. Bonini-Domingos, V. D. Fraga, L. M. Conceição, A. R. B. Rossit, C. E. Cavasini, V. S. C. D. Couto, and R. L. D. Machado. 2008. Mixed Plasmodium faciparum infections and its clinical implications in four areas of the Brazilian Amazon region. Acta Trop. 107:8-12.
22. Luxemburger, C., N. J. White, F. ter Kuile, H. M. Singh, I. Allier-Frachon, M. Ohn, T. Chongsuphajaisiddhi, and F. Nosten. 1996. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 90:105-111.
23. May, J., and C. G. Meyer. 2003. Chemoresistance in falciparum malaria. Trends Parasitol. 19:432-435. (Pubitemid 38366136)
24. Mayxay, M., S. Pukrittayakamee, P. N. Newton, and N. J. White. 2004. Mixed-species malaria infections in humans. Trends Parasitol. 20:233-240. (Pubitemid 38510320)
25. Mbaisi, A., P. Liyala, F. Eyase, R. Achilla, H. Akala, J. Wangui, J. Mwangi, F. Osuna, U. Alam, B. L. Smoak, J. M. Davis, D. E. Kyle, R. L. Coldren, C. Mason, and N. C. Waters. 2004. Drug susceptibility and genetic evaluation of Plasmodium falciparum isolates obtained in four distinct geographical regions of Kenya. Antimicrob. Agents Chemother. 48:3598-3601.
26. Milhous, W. K., N. F. Weatherly, J. H. Bowdre, and R. E. Desjardins. 1985. In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrob. Agents Chemother. 27:525-530.
27. Molineaux, L., J. Storey, J. E. Cohen, and A. Thomas. 1980. A longitudinal study of human malaria in the west African savanna in the absence of control measures: relationships between different Plasmodium species; in particular Plasmodium falciparum and Plasmodium malariae. Am. J. Trop. Med. Hyg. 29:725-737. (Pubitemid 11250918)
28. Nakornchai, S., and P. Konthiang. 2006. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. Acta Trop. 100:185-191.
29. Oduola, A. M., N. F. Weatherly, J. H. Bowdre, and R. E. Desjardins. 1988. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Exp. Parasitol. 66:86-95.
30. Ohrt, C., G. D. Willingmyre, P. Lee, C. Knirsch, and W. Milhous. 2002. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 46:2518-2524.
31. Plouffe, D., A. Brinker, C. McNamara, K. Henson, N. Kato, K. Kuhen, A. Nagle, F. Adrián, J. T. Matzen, P. Anderson, T. G. Nam, N. S. Gray, A. Chatterjee, J. Janes, S. F. Yan, R. Trager, J. S. Caldwell, P. G. Schultz, Y. Zhou, and E. A. Winzeler. 2008. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc. Natl. Acad. Sci. USA 105:9059-9064.
32. Postigo, M., A. Mendoza-León, and H. A. Pérez. 1998. Malaria diagnosis by the polymerase chain reaction: a field study in south-eastern Venezuela. Trans. R. Soc. Trop. Med. Hyg. 92:509-511.
33. Rason, M. A., T. Radriantsoa, H. Andrianatenaina, A. Ratsimbasoa, and D. Menard. 2008. Performance and reliability of the SYBR green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. Trans. R. Soc. Trop. Med. Hyg. 102:346-351.
34. Richie, T. L. 1988. Interactions between malarial parasites infecting the same vertebrate host. Parasitology 96:607-639. (Pubitemid 19322306)
35. Sanders, J. W., G. S. Fuhrer, M. D. Johnson, and M. S. Riddle. 2008. The epidemiological transition: the current status of infectious diseases in the developed world versus the developing world. Sci. Prog. 91:1-37.
36. Smilkstein, M., N. Sriwilaijaroen, J. X. Kelly, P. Wilairat, and M. Riscoe. 2004. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial screening. Antimicrob. Agents Chemother. 48:1803-1806.
37. Ursos, L. M., and P. D. Roepe. 2002. Chloroquine resistance in the malarial parasite, Plasmodium falciparum. Med. Res. Rev. 22:465-491.
38. Weisman, J. L., A. P. Liou, A. A. Shelat, F. E. Cohen, R. K. Guy, and J. L. DeRisi. 2006. Searching for new antimalarial therapeutics amongst known drugs. Chem. Biol. Drug Des. 67:409-416.
39. WHO. 2008. World malaria report 2008. World Health Organization, Geneva, Switzerland.
40. Willet, G. P., W. K. Milhous, L. Gerena, and A. M. J. Oduola. 1991. Mixed population dynamics in human malaria parasite cultures. Trans. R. Soc. Trop. Med. Hyg. 85:33-34.
41. Wongsrichanalai, C., and S. R. Meshnick. 2008. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg. Infect. Dis. 14:716-719.
42. Zimmerman, P. A., R. K. Mehlotra, L. J. Kasehagen, and J. W. Kazura. 2004. Why do we need to know more about mixed Plasmodium species infections in humans? Trends Parasitol. 20:440-447.